Qube Research & Technologies Ltd - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,310,448
-62.6%
114,250
-17.6%
0.00%
-76.9%
Q2 2023$3,507,890
+105.4%
138,597
+161.4%
0.01%
+85.7%
Q1 2023$1,707,806
-34.8%
53,021
-62.6%
0.01%
-50.0%
Q4 2022$2,619,105
+238.4%
141,880
+394.9%
0.01%
+180.0%
Q3 2022$774,000
+11.4%
28,669
+22.3%
0.01%
-37.5%
Q2 2021$695,000
+92.5%
23,435
+63.3%
0.01%
+60.0%
Q3 2020$361,000
+12.8%
14,353
+9.4%
0.01%0.0%
Q2 2020$320,00013,1170.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders